Intrexon will take the name of its subsidiary. That company just scored orphan status for a rare cancer drug. By: Washington Business Journal via Business Journals January 06, 2020 at 17:14 PM EST The win comes just days after Intrexon put plans in motion to rebrand. Read More >>